Science for All: Krill don't have jet lag, thanks to their circadian rhythm
Krill (Euphausia superba) are transparent marine organisms. Each krill is the size of a matchbox but they travel the open seas in swarms of several thousands. They are prey to millions of seals, penguins, and whales in the Southern Ocean, a rapidly warming water body whose temperature has significant effects on tropical rainfall.
All organisms have an internal clock called the circadian rhythm that syncs with the day/night cycle. If the natural cycle is interrupted, so is the rhythm. This is why you have jet lag. Yet krill have been found to have a circadian rhythm that ticks on even when their days and nights are distorted.
Researchers from Germany and the U.K. recently reported this finding in eLife.
Every day, krill move to the surface of the ocean and back down to feed and fend off predators. This collective swimming is called diel vertical migration (DVM). They tend to move towards the surface at night and to the depths during the day.
The study took a closer look at the mechanism that drives DVM.
'We know that krill move up and down in the water column each day which also has important implications on nutrient cycling and carbon sequestration, but we don't know what mechanism governs this behaviour. This study sheds light on that, and will help us better understand and conserve this incredible species,' Matthew Savoca, a research scientist at the Hopkins Marine Station of Stanford University and who wasn't involved in the study, said.
In 2024, the team developed a device called Activity Monitor for Aquatic Zooplankter (AMAZE). It's an observation incubator with 80-cm-long acrylic glass columns. Laser light is passed through the columns. When krill swim through them, they interrupt the laser light, which a detector records to track the krill's movement.
For the experiment, the researchers collected krill from the Bransfield Strait and the South Orkney Islands located about 800 km and 1,250 km southeast, respectively, from the bottom tip of South America.
They divided the samples into two groups. The first was immediately transferred to AMAZE, which simulated the natural durations of day and night around the islands. Some days were short (5.5 hours) and others much longer (15 hours). Then the krill were placed in complete darkness for 4-8 days.
The scientists observed the second group of kill in their natural conditions using hydroacoustics, then they were moved to AMAZE and kept in darkness. Researchers studied the second group in conditions corresponding to the four seasons.
Krill's DVM activity increased towards the night and decreased during morning hours. Notably, the scientists found that when DVM began or ended was fixed to daytime and nighttime whenever they happened, rather than to particular hours of the day. In fact the krill maintained the same DVM patterns even in complete darkness.
If the days were long, the krill fed for fewer hours. And if nights were longer, they fed for longer and in phases.
As krill move across the ocean via currents, they influence the lives of many other creatures around them.
Lukas Hüppe, a doctoral researcher at the University of Würzburg in Germany and coauthor of the study, expressed optimism about the findings' implications for the Southern Ocean ecosystem, which centres around this species.
'The findings provide novel insights into the mechanistic underpinnings of daily and seasonal timing in Antarctic krill, a marine pelagic key species, endemic to a high-latitude region,' the researchers wrote in their paper. 'Mechanistic studies are a prerequisite for understanding how krill adapt to their specific environment and their flexibility in responding to environmental changes.'
Manaswini Vijayakumar is interning with The Hindu.
From the Science pages
Question Corner
What is synthetic aperture radar? Find out here
Flora and fauna
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Deccan Herald
4 hours ago
- Deccan Herald
Virtual labs with AI scientists show promise: Stanford study
Virtual scientists in a virtual lab at Stanford University are coming up with unorthodox ways to address clinical challenges, researchers reported on Tuesday in Nature. The virtual lab is modeled after a well-established Stanford School of Medicine research group, complete with a principal investigator and seasoned scientists, the report says. As in human-run research labs, the virtual lab has regular meetings during which agents generate ideas and engage in a conversational back-and-forth. They also have one-on-one meetings, allowing the virtual lab members to meet with the virtual principal investigator individually to discuss ideas. Unlike human meetings, the virtual gatherings take a few seconds or minutes. When humans tasked the virtual team with devising a better vaccine for the SARS-CoV-2 virus that causes COVID-19, they equipped the virtual scientists with tools and software to stimulate creative 'thinking' skills. The virtual scientists even created their own wish list. 'They would ask for access to certain tools, and we'd build it into the model to let them use it,' study leader James Zou said in a statement. Instead of opting for the usual vaccine design using an antibody, the AI team came up with using a nanobody, an antibody fragment that's smaller and simpler. 'From the beginning of their meetings, the AI scientists decided that nanobodies would be a more promising strategy,' Zou said. 'They said nanobodies are typically much smaller than antibodies, so that makes the machine learning scientist's job much easier," Zou said, "because when you computationally model proteins, working with smaller molecules means you can have more confidence in modeling and designing them.' When humans created the AI researchers' nanobody in a real-world lab, they found it was stable and could attach itself to one of the COVID virus variants more tightly than existing antibodies - a key factor in determining vaccine effectiveness. Aside from the initial prompt, the main guideline consistently given to the AI lab members was budget-related. Zou estimates that he or his lab members intervene about 1% of the time. 'I don't want to tell the AI scientists exactly how they should do their work. That really limits their creativity,' Zou said. 'I want them to come up with new solutions and ideas that are beyond what I would think about.'
Time of India
a day ago
- Time of India
Virtual labs with AI scientists produce promising result in Stanford study
Virtual scientists in a virtual lab at Stanford University are coming up with unorthodox ways to address clinical challenges, researchers reported on Tuesday in Nature. The virtual lab is modeled after a well-established Stanford School of Medicine research group, complete with a principal investigator and seasoned scientists, the report says. As in human-run research labs, the virtual lab has regular meetings during which agents generate ideas and engage in a conversational back-and-forth. They also have one-on-one meetings, allowing the virtual lab members to meet with the virtual principal investigator individually to discuss ideas. Unlike human meetings, the virtual gatherings take a few seconds or minutes. When humans tasked the virtual team with devising a better vaccine for the SARS-CoV-2 virus that causes COVID-19, they equipped the virtual scientists with tools and software to stimulate creative "thinking" skills. The virtual scientists even created their own wish list. "They would ask for access to certain tools, and we'd build it into the model to let them use it," study leader James Zou said in a statement. Instead of opting for the usual vaccine design using an antibody, the AI team came up with using a nanobody, an antibody fragment that's smaller and simpler. "From the beginning of their meetings, the AI scientists decided that nanobodies would be a more promising strategy," Zou said. "They said nanobodies are typically much smaller than antibodies, so that makes the machine learning scientist's job much easier," Zou said, "because when you computationally model proteins, working with smaller molecules means you can have more confidence in modeling and designing them." When humans created the AI researchers' nanobody in a real-world lab, they found it was stable and could attach itself to one of the COVID virus variants more tightly than existing antibodies - a key factor in determining vaccine effectiveness. Aside from the initial prompt, the main guideline consistently given to the AI lab members was budget-related. Zou estimates that he or his lab members intervene about 1% of the time. "I don't want to tell the AI scientists exactly how they should do their work. That really limits their creativity," Zou said. "I want them to come up with new solutions and ideas that are beyond what I would think about." SCIENTISTS FIND GENES THAT CAUSE STUTTERING A new study found a clear genetic basis for stuttering, the speech disorder that affects more than 400 million people worldwide. Overall, as reported in Nature Genetics, the researchers identified 57 distinct regions on 48 genes associated with stuttering. Some of the same genetic variants involved in stuttering can also contribute to autism, depression and musicality, they found. Stuttering, characterized by syllable and word repetitions, sound prolongations, and breaks between words, is the most common fluency disorder, the researchers said. "There have been hundreds of years of misconceptions about what causes stuttering, from ideas about left-handedness to childhood trauma to overbearing mothers," study leader Jennifer (Piper) Below of Vanderbilt University Medical Center in Nashville said in a statement. "Rather than being caused by personal or familial failings or intelligence, our study shows that stuttering is influenced by our genes." Young people who stutter report increased bullying, decreased classroom participation, and a more negative educational experience, her team noted. Stuttering can also negatively impact employment opportunities and perceived job performance, as well as mental and social well-being. Dillon Pruett, a postdoctoral fellow at Vanderbilt and a co-author of the study, stutters. "As someone personally affected, I wanted to contribute to this body of research," he said. "Our study found that there are many genes that ultimately contribute to stuttering risk, and we hope to use this knowledge to dispel stigma related to stuttering and also to hopefully develop new therapeutic approaches in the future." AT THE SIGHT OF A SICK PERSON, THE BRAIN GOES ON ALERT At the mere sight of a possibly contagious person, the human brain launches its germ-fighting preparations, researchers say. In virtual reality experiments using Google's Oculus Rift headsets, 248 healthy young adults were approached by human-like avatars, some of which showed visible signs of infection, such as rashes or coughing. Other avatars appeared neutral or fearful. As the infectious avatars moved closer, noninvasive monitoring showed changes in brain regions involved in integrating awareness of the body's position, movement, and relationship to the surrounding environment, which was not seen in response to the approaching neutral or fearful faces, the researchers reported in Nature Neuroscience. Participants were more reactive to touch when the sick-looking avatars were nearby, the researchers also found. Blood samples showed that exposure to the infectious-appearing avatars triggered an increase in volunteers' innate lymphoid cell activity, a key component of the immune system, which is typically seen during responses to real infections or vaccines. The results illustrate the power of the brain "to predict what is going on (and) to select the proper response," study co-author Andrea Serino of University Hospital of Lausanne, Switzerland said in an accompanying news article in the journal.
News18
3 days ago
- News18
How Many Lives Did Covid-19 Vaccines Save? New Global Study Reveals The Numbers
Last Updated: According to the research, 82% of the lives saved involved individuals who had received the vaccine before being infected by the coronavirus A new international study has revealed that Covid-19 vaccines saved more than 25 lakh lives between 2020 and 2024, highlighting the profound global impact of mass immunisation efforts during the pandemic. The study, published in the JAMA Health Forum, was jointly conducted by researchers from Universita Cattolica in Italy and Stanford University in the US. It estimates that around 25.33 lakh lives were spared due to vaccination, with one death averted for every 5,400 doses administered. Covid-19 first emerged in Wuhan, China, in late 2019 and swept across the globe within months, triggering unprecedented health, economic, and social crises. In response, scientists raced to develop vaccines, and by the end of 2020, several versions were rolled out worldwide. Billions received two primary doses, with many also taking booster shots. While questions were occasionally raised about the vaccine's long-term effects, particularly concerning heart-related issues, health experts repeatedly dismissed such claims, maintaining that the benefits far outweighed any rare side effects. The new study offers quantitative backing to those assertions. Elderly Benefited Most The researchers found the vaccine's impact was most significant among those aged 60 and above. In this age group, the vaccine prevented 90% of potential deaths. Of the estimated 1.48 crore life-years saved globally, 76% were among the elderly. Moreover, 82% of the lives saved involved individuals who had received the vaccine before being infected by the virus. The protection was particularly evident during the Omicron wave, a highly infectious phase of the pandemic that alone accounted for 57% of the prevented deaths. Limited Impact on Children and Youth In contrast, the benefit of vaccination among children and young adults was marginal, largely due to their lower baseline risk of death from Covid-19. For individuals aged 0 to 19, the number of lives saved was just 0.01%, while life-years saved stood at 0.1%. For those aged 20 to 29, deaths prevented amounted to 0.07%, with 0.3% life-years gained. Global Data, Comprehensive Scope The study was led by Professor Stefania Boccia from Universita Cattolica, in collaboration with Dr Angelo Maria Pezzullo and Dr Antonio Christiano, both affiliated with Stanford University under a European research initiative. Their analysis drew on global data concerning Covid-19 infections, mortality, and vaccine distribution. Using statistical modelling, the team estimated how many more people might have died in a scenario without vaccines. What sets this study apart is its scale and scope. It is the first global research effort covering the full timeline of the pandemic – from the early days in 2020 through to 2024. It not only compares outcomes among vaccinated and unvaccinated populations but also measures the difference in impact across different virus variants, especially before and after Omicron emerged. Beyond deaths prevented, the research also sheds light on the concept of 'life-years saved", a measure that considers not just whether a life was saved, but how many more years that person might live. This adds further depth to understanding the vaccine's role in mitigating the Covid-19 pandemic's toll. view comments First Published: July 29, 2025, 15:03 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
